Centrient is the new name

11 December 2018 - 0 Submitted by Andrew Warmington

DSM Sinochem Pharmaceuticals has new identity under private equity owner

Singapore-based DSM Sinochem Pharmaceuticals (DSP) has been renamed Centrient Pharmaceuticals with effect from 10 December. This follows the completion in October of its sale from the joint ownership of DSM and the Sinochem Group to Bain Capital Private Equity.

“The name Centrient emphasises the way in which we operate: putting our brand promise of ‘Quality, Reliability and Sustainability’ at the centre of everything we do,” said CEO Karl Rotthier. “Our bold and creative new name and logo showcase our company as one which prides itself on being at the centre of modern healthcare, through our life-saving APIs and finished dosage forms.”

DSP was originally formed in 2011 as a 5-50 joint venture. In 2017, it had sales of about €440 million, with manufacturing sites and sales offices in China, India, the Netherlands, Spain, the US and Mexico, employing some 2,000 people. It makes pharmaceutical intermediates, APIs and finished dosage forms, with particularly strengths in beta-lactam antibiotics, statins and anti-fungals.

The company will also adopt a corporate brand identity and website. It stated that it “will provide further updates to customers, suppliers and partners regarding these changes to ensure a smooth transition in the implementation of the new name”.

What does digitization mean for the chemicals industry?

May 22, 2019/0

In partnership with consulting firm EY, Speciality Chemicals Magazine is launching a survey of the state of digtalization in the chemicals industry. And we need your help! It is entirely confidential, based on mainly multiple choice questions and should only take 5 minutes to complete.

Thermo Fisher buys GSK Irish site

May 20, 2019/0

Thermo Fisher Scientific, owner of Patheon, has agreed to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline (GSK) for about €90 million. The deal should be completed by the end of 2019, subject to regulatory approvals and other customary closing condition.

Queen's Awards for four UK-based chemical operations

Apr 25, 2019/0

Four companies with operations in the UK have been honoured in the latest round of the Queen’s Award for Enterprise. Diamond Dispersions, Sterling Pharma Solutions and Leverton Clarke all won in the International Trade category, Biocatalysts in the Innovation category.

Ten die in Chinese pharma plant accident

Apr 25, 2019/0

Ten workers were killed in an accident at a pharmaceutical intermediates and APIs plant in China’s Shandong province on 15 April, it has emerged. This was the second fatal industrial accident at a chemicals-related plant in China within the space of a month.

Envigo and Covance in asset swap

Apr 25, 2019/0

Envigo’s Research Models Services business is to acquire the Research Products business of LabCorp’s Covance subsidiary, becoming a pure-play research models and services business.

Authorities close China blast park

Apr 09, 2019/0

Repercussions are continuing from the blast at the Chenjiagang Chemical Industry Park in Xiangshui, China, on 21 March, which killed 78 people and injured over 600 more.